GB0810228D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0810228D0 GB0810228D0 GBGB0810228.7A GB0810228A GB0810228D0 GB 0810228 D0 GB0810228 D0 GB 0810228D0 GB 0810228 A GB0810228 A GB 0810228A GB 0810228 D0 GB0810228 D0 GB 0810228D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0810228.7A GB0810228D0 (en) | 2008-06-04 | 2008-06-04 | Novel compounds |
| EP09757293A EP2310370A1 (en) | 2008-06-04 | 2009-06-04 | 4, 6-diphenylpyrid-2-ones against cancer |
| CA2726939A CA2726939A1 (en) | 2008-06-04 | 2009-06-04 | 4,6-diphenylpyrid-2-ones against cancer |
| US12/478,587 US8236827B2 (en) | 2008-06-04 | 2009-06-04 | Compounds |
| JP2011512021A JP2011521986A (ja) | 2008-06-04 | 2009-06-04 | 癌に対する４，６−ジフェニルピリド−２−オン |
| PCT/EP2009/004005 WO2009146910A1 (en) | 2008-06-04 | 2009-06-04 | 4, 6-diphenylpyrid-2-0nes against cancer |
| AU2009254176A AU2009254176A1 (en) | 2008-06-04 | 2009-06-04 | 4, 6-diphenylpyrid-2-0nes against cancer |
| US13/557,508 US20130023567A1 (en) | 2008-06-04 | 2012-07-25 | Novel Compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0810228.7A GB0810228D0 (en) | 2008-06-04 | 2008-06-04 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0810228D0 true GB0810228D0 (en) | 2008-07-09 |
Family
ID=39638174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0810228.7A Ceased GB0810228D0 (en) | 2008-06-04 | 2008-06-04 | Novel compounds |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8236827B2 (enExample) |
| EP (1) | EP2310370A1 (enExample) |
| JP (1) | JP2011521986A (enExample) |
| AU (1) | AU2009254176A1 (enExample) |
| CA (1) | CA2726939A1 (enExample) |
| GB (1) | GB0810228D0 (enExample) |
| WO (1) | WO2009146910A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012058550A2 (en) * | 2010-10-29 | 2012-05-03 | Fox Chase Cancer Center | Methods for screening compounds for capability to inhibit premalignant squamous epithelial cell progression to a malignant state |
| US9101603B2 (en) | 2010-11-30 | 2015-08-11 | Institute For Cancer Research | Targeting of CYP1B1 in the treatment of head and neck cancer and lung cancer |
| CN103387574A (zh) * | 2012-05-07 | 2013-11-13 | 北京以岭药业有限公司 | 一种表小檗碱的合成方法 |
| CN107591180A (zh) * | 2016-07-07 | 2018-01-16 | 中芯国际集成电路制造(上海)有限公司 | 非挥发性存储器及其读取数据的方法 |
| EP3484864A1 (en) * | 2016-07-13 | 2019-05-22 | Centre National de la Recherche Scientifique - CNRS | Pyrimidinone derivatives and uses thereof to neutralize the biological activity of chemokines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0123777D0 (en) | 2001-10-03 | 2001-11-21 | Cancer Res Ventures Ltd | Substituted chalcones as therapeutic agents |
| US7910742B2 (en) * | 2005-09-29 | 2011-03-22 | Abbott Laboratories | Survivin inhibitors |
| US8242129B2 (en) | 2007-04-25 | 2012-08-14 | Exelixis, Inc. | 6-phenylpyrimidinones as PIM modulators |
-
2008
- 2008-06-04 GB GBGB0810228.7A patent/GB0810228D0/en not_active Ceased
-
2009
- 2009-06-04 CA CA2726939A patent/CA2726939A1/en not_active Abandoned
- 2009-06-04 US US12/478,587 patent/US8236827B2/en not_active Expired - Fee Related
- 2009-06-04 AU AU2009254176A patent/AU2009254176A1/en not_active Abandoned
- 2009-06-04 WO PCT/EP2009/004005 patent/WO2009146910A1/en not_active Ceased
- 2009-06-04 EP EP09757293A patent/EP2310370A1/en not_active Withdrawn
- 2009-06-04 JP JP2011512021A patent/JP2011521986A/ja active Pending
-
2012
- 2012-07-25 US US13/557,508 patent/US20130023567A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20130023567A1 (en) | 2013-01-24 |
| CA2726939A1 (en) | 2009-12-10 |
| US20100168180A1 (en) | 2010-07-01 |
| US8236827B2 (en) | 2012-08-07 |
| AU2009254176A1 (en) | 2009-12-10 |
| JP2011521986A (ja) | 2011-07-28 |
| WO2009146910A8 (en) | 2011-04-07 |
| EP2310370A1 (en) | 2011-04-20 |
| WO2009146910A1 (en) | 2009-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0823467D0 (en) | Novel Compounds | |
| GB0806536D0 (en) | Novel compounds | |
| GB0800035D0 (en) | Compounds | |
| GB0813142D0 (en) | Novel compounds | |
| GB0808747D0 (en) | Novel compounds | |
| GB0811587D0 (en) | Novel Compounds | |
| IL212799A0 (en) | Novel compounds | |
| GB0812849D0 (en) | Novel compounds | |
| GB0804592D0 (en) | Novel compounds | |
| GB0800367D0 (en) | Compounds | |
| GB0810981D0 (en) | Novel compounds | |
| IL213032A0 (en) | Novel compounds | |
| GB0813144D0 (en) | Novel compounds | |
| GB0808030D0 (en) | Novel compounds | |
| GB0804326D0 (en) | Novel compounds | |
| GB0711521D0 (en) | Novel compounds | |
| GB0800411D0 (en) | Novel compounds | |
| GB0809479D0 (en) | Novel compounds | |
| GB0805272D0 (en) | Novel compounds | |
| GB0803306D0 (en) | Novel compounds | |
| GB0804414D0 (en) | Novel compounds | |
| GB0805047D0 (en) | Novel compounds | |
| GB0810313D0 (en) | Novel compounds | |
| GB0821169D0 (en) | Novel compounds | |
| GB0806368D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |